| Product NDC: | 65862-465 |
| Proprietary Name: | Famciclovir |
| Non Proprietary Name: | Famciclovir |
| Active Ingredient(s): | 125 mg/1 & nbsp; Famciclovir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65862-465 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091114 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110321 |
| Package NDC: | 65862-465-50 |
| Package Description: | 5 BLISTER PACK in 1 CARTON (65862-465-50) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| NDC Code | 65862-465-50 |
| Proprietary Name | Famciclovir |
| Package Description | 5 BLISTER PACK in 1 CARTON (65862-465-50) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 65862-465 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Famciclovir |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20110321 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | FAMCICLOVIR |
| Strength Number | 125 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |